Health information to help you understand symptoms. It isn't a diagnosis.
Check symptoms

Research deep dives

Leukemia is a cancer of the factory, not a lump

Last reviewed November 16, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.

Nearly every other cancer is explained by where the lump is. Leukemia has no lump. It begins in the spongy tissue inside your bones, which produces roughly two hundred billion red blood cells, a hundred billion white cells and a similar number of platelets every single day.

Once you picture the marrow as a factory running at that pace, the symptoms stop looking like a random list.

Illustration of large purple leukemia blast cells packed among smaller orange-red blood cells.
Large, immature leukemia cells, called blasts, packed in among red blood cells. Blasts cannot carry oxygen, help blood clot or fight infection, and as they fill the marrow they push out the cells that can. That single picture explains the fatigue, the bruising and the repeated infections.Illustration created for OwieClear. A drawing, not a photograph of a real sample.

Related pages: Leukemia (blood cancer)

The bottom line

What we know
  • Leukemia begins in blood-forming cells in the bone marrow.
  • The marrow makes cells along two lines, myeloid and lymphoid, and leukemias are named for which line went wrong.
  • Leukemic cells crowd and suppress normal blood production, causing low red cells, low platelets and low working white cells.
  • The classic symptoms, fatigue, bruising and infections, are the direct result of those three shortages.
What is still open
  • Exactly how leukemic cells suppress normal blood production, since it is not simply a matter of physical space.
  • Why some people's marrow recovers quickly after treatment and others' does not.

The story, step by step

  1. 1. The factory ()
  2. 2. The jam ()
  3. 3. The crowding ()
  4. 4. The spill ()
  5. 5. The tests ()
What the evidence labels mean
GuidelineAn official recommendation from an expert group after weighing all the evidence.
Review of many studiesCombines the results of many studies (a systematic review or meta-analysis).
Randomized trialPeople were randomly given a treatment or a comparison, the best way to test cause and effect.
Large observational studyFollows many people over time. Shows strong links, but not always cause and effect.
Small or early studyA small study, case series, or first results. Needs to be confirmed.
Lab or animal studyDone in cells or animals. May not apply to people.
Part 1 of 5

Two production lines from one stem cell

Review of many studies

What happens

All blood cells descend from hematopoietic stem cells living in the marrow.

What the research shows

  • The myeloid line makes red blood cells, platelets and the fast-acting white cells such as neutrophils and monocytes.
  • The lymphoid line makes B-cells, T-cells and natural killer cells, the part of immunity that learns.
  • Each cell passes through stages, becoming more specialized at each step, then stops dividing and does its job.
  • A neutrophil lives about a day. A red blood cell lives about four months. The factory never stops.

Why it matters

Every leukemia is named for which line it came from and how fast it moves, so this one diagram explains the whole naming system.

What's still uncertain

  • Where the exact branch point is between the two lines has been revised several times as single-cell methods improved.

Read more

Next: The jam

Part 2 of 5

Cells that never grow up

Lab or animal study

What happens

In leukemia, the problem is usually not that cells divide faster. It is that they never finish growing up.

What the research shows

  • Mutations lock a precursor cell at an immature stage. Those stuck cells are called blasts.
  • A blast cannot do the job of a mature cell. It cannot fight infection, carry oxygen, or help blood clot.
  • Normal blood cells are built to die on a schedule. Leukemic cells often lose that instruction and accumulate.
  • In the acute leukemias blasts build up quickly, over days to weeks. In the chronic ones, cells mature further and accumulate more slowly, over years.

Why it matters

This is why someone can have a sky-high white cell count and still be dangerously vulnerable to infection: the count is high, but almost none of those cells work.

What's still uncertain

  • Why the same mutation causes aggressive disease in one person and indolent disease in another is not fully understood.

Read more

Next: The crowding

Part 3 of 5

Three shortages, three sets of symptoms

Review of many studies

What happens

The marrow is a fixed space, and normal production falls as leukemic cells take over. The symptoms map onto exactly which cell type is short.

What the research shows

  • Too few red blood cells, anemia: tiredness, pale skin, breathlessness, a fast heartbeat.
  • Too few platelets, thrombocytopenia: easy bruising, nosebleeds, bleeding gums, and tiny flat red or purple dots called petechiae.
  • Too few working neutrophils, neutropenia: infections that keep coming back, or fever with no obvious cause.
  • Crowding is the traditional explanation, but leukemic cells also actively suppress normal blood production through signals they release and by remodelling the marrow environment itself.

Why it matters

A combination of these three, especially bruising plus fever plus fatigue together, is what should prompt a blood count rather than a wait-and-see.

What's still uncertain

  • How much of the shortfall is physical crowding and how much is active suppression is still being worked out.

Read more

Next: The spill

Part 4 of 5

Out of the marrow and into everything else

Review of many studies

What happens

The word leukemia means white blood, and it was coined because someone noticed the blood itself looked wrong.

What the research shows

  • When the marrow overflows, leukemic cells enter the bloodstream, which is what makes them visible on a routine blood test.
  • From there they can settle in the lymph nodes, spleen and liver, which is why those organs can enlarge.
  • Some leukemias infiltrate the gums, the skin, the testes, or the fluid around the brain and spinal cord.
  • Because of that last possibility, treatment for acute lymphoblastic leukemia routinely includes medicine given into the spinal fluid, where ordinary chemotherapy does not reach well.

Why it matters

A cancer that travels in the blood from the start is why leukemia is treated with drugs that reach the whole body rather than with surgery.

What's still uncertain

  • Which patients will develop central nervous system involvement cannot be predicted reliably, which is why prevention is given to everyone with ALL.

Read more

Next: The tests

Part 5 of 5

Why a blood count comes first, and a marrow sample second

Review of many studies

What happens

The diagnostic sequence follows directly from the biology above.

What the research shows

  • A complete blood count shows the shortages and often shows abnormal cells.
  • A blood smear lets someone look at the cells themselves under a microscope.
  • A bone marrow aspirate and biopsy sample the factory directly and are what confirm the diagnosis.
  • Flow cytometry, cytogenetics and gene sequencing then identify the exact subtype and the driver mutations, which is what decides treatment.

Why it matters

The subtype is not a technicality. Two leukemias that look identical down a microscope can have completely different treatments and outlooks depending on the genetics.

What's still uncertain

  • Results of the genetic tests take days to weeks, so treatment sometimes starts before the full picture is known.

Read more

More plain-language reading

See something wrong or unclear on this page? Suggest a correction. OwieClear is for education only and isn't medical advice.